NCT00051987 2008-02-11Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal CarcinomaMillennium Pharmaceuticals, Inc.Phase 2 Completed175 enrolled